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Rapid late-stage introduction of fluorine into biologi-
cally active compounds is essential for the synthesis of 18F-
labeled radiotracers for positron emission tomography.1-3 
Although significant advances in electrophilic radiofluo-
rination have been made recently,4 nucleophilic, fluoride-
based approaches to radiotracers are preferred in imag-
ing applications where radiochemical purity is essential.5 
For aromatic compounds bearing electron-withdrawing 
groups, nucleophilic aromatic substitution (SNAr) of ha-
lide, nitro, or trimethylamine leaving groups by fluoride 
is a highly efficient process.6-10 However, functionalization 
of electron-rich arenes with fluoride requires mediation by 
transition metal11 or hypervalent main group atoms.
The reductive elimination of aryl fluorides from diaryl-
iodonium salts was pioneered by Pike for arene radioflu-
orination.12-14 Aided by our access to anhydrous fluoride 
reagents,15 we were able to demonstrate that removal of in-
organic salts from the reaction medium and the use of rela-
tively nonpolar solvents dramatically increase the yields of 
fluorinated arenes from diaryliodonium fluorides.16 Here 
we address some of the remaining roadblocks to efficient 
fluorination using I(III) compounds.
Published in Organic Letters 13:12 (2011), pp. 3158–3161; doi: 10.1021/ol201080c   
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Abstract
For the first time it is shown that exceptionally electron-rich arene rings can be fluorinated exclusively during 
the reductive elimination reactions of diaryliodonium fluorides. The 5-methoxy[2.2]paracyclophan-4-yl directing 
group simultaneously reduces unproductive aryne chemistry and eliminates ligand exchange reactions by a com-
bination of steric and electronic effects. Use of the cyclophane directing group permits an unprecedented degree 
of control in fluorination reactions of diaryliodonium salts.
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The reductive elimination regiochemistry of diaryli-
odonium fluorides is generally controlled by electronic 
substituent effects; the most electron-poor ring is fluo-
rinated selectively, and the electron-rich aryl iodide is 
eliminated. However, the extent to which electronic con-
trol can be utilized is limited, since highly electron-rich 
rings promote nonproductive decomposition reactions 
of diaryliodonium salts, presumably by inner-sphere re-
dox processes. As an example, diaryliodonium salts fea-
turing 4-(dialkylamino)phenyl groups have not been iso-
lated, despite attempts to do so.17 A second consideration 
is the surprisingly labile nature of aryl rings on I(III) fluo-
rides; we demonstrated recently that rapid aryl group ex-
change among diaryliodonium fluorides occurs at room 
temperature in acetonitrile.18 Here we show that appro-
priately substituted cyclophane ligands on iodine solve 
simultaneously the ligand exchange and regiospecific-
ity problems by means of the same stereoelectronic effect. 
 
 
 
Paracyclophane substituents have been shown to be su-
perior directing groups for reductive elimination reactions 
of diaryliodonium salts;19 regiospecificity is obtained even 
when electron-rich aryl rings, such as 4-methoxyphenyl, 
are functionalized. Significant out of plane steric bulk pro-
vided by the “capping” aryl ring results in a highly con-
gested, strongly destabilized (by >4 kcal/mol) transition 
state for cyclophane functionalization. A rise in the free en-
ergy of activation for cyclophane functionalization steers 
the nucleophile toward the second aryl substituent. Regio-
specific arene functionalization was demonstrated with the 
weakly basic azide, acetate, phenoxide, thiocyanate, and 
thiophenoxide nucleophiles. However, regiocontrol was 
lost when the more strongly basic trifluoroethoxide nu-
cleophile was used; this basic group appeared to promote 
a mode of decomposition that involved formation of aryne 
intermediates.19 The similar basicities of fluoride and triflu-
oroethoxide in polar aprotic solvents (CF3CH2OH, pKa = 
23.5; HF, pKa = 15 in DMSO)20 implied that aryne chemis-
try could also be a significant side reaction in cyclophane 
directed fluorinations of diaryliodonium salts.
(4-Methoxyphenyl)([2.2]paracyclophan-4-yl)iodo-
nium hexafluorophosphate 1(PF6) and (4-methoxyphenyl)
((7-methoxy[2.2]paracyclophan-4-yl)iodonium hexafluo-
rophosphate 2(PF6) (Figure 1) were prepared as described 
previously19 and converted to the fluoride salts by ion ex-
change with anhydrous tetramethylammonium fluoride21 
(TMAF) in acetonitrile. The residual TMAPF6 was removed 
by evaporation of the solvent, suspension of the remain-
ing solid in benzene, and passage of this solution through 
a 0.2 μm PTFE filter. NMR (1H and 19F) and ES-MS spec-
tra of 1(F) and 2(F) were consistent with a single species 
in solution, indicating that fluoride-promoted aryl group 
exchange in diaryliodonium fluorides is suppressed by 
the cyclophane substituent. Thermal decomposition reac-
tions of 1(F) and 2(F) (140 °C, d6-benzene, 15 min) gave a 
mixture of fluorinated products (Figure 2). The relatively 
poor selectivity observed for arene fluorination contrasts 
strongly with the excellent selectivity observed previously 
for weakly basic nucleophiles (Table 1). Tellingly, roughly 
equal amounts of 4-fluoro-7-methoxy[2.2]paracyclophane 
and 4-fluoro-8-methoxy[2.2]paracyclophane were formed 
during the thermal decomposition reaction of 2(F), impli-
cating arynes as likely reactive intermediates. Although the 
greater susceptibility of the relatively electron-rich cyclo-
phane ligand to deprotonation is not well understood cur-
rently, we pursued a simple blocking strategy to suppress 
aryne formation and to restore regiocontrol.
(4-Methoxyphenyl)(5-methoxy[2.2]paracyclophan-4-yl)
iodonium hexafluorophosphate, 3(PF6), in which both sites 
ortho to the I(III) center are substituted, was synthesized 
from 4-bromo[2.2]paracyclophane,22 as is shown in Figure 
3. Metal–halogen exchange yielded the organolithium re-
agent, which was quenched with trimethylborate and ox-
idized with hydrogen peroxide.23 To introduce a halogen 
Figure 1. Numbering of the [2.2]paracyclophane ring system and the 
structures of the diaryliodonium hexafluorophosphate salts discussed 
in this work.
17. Beringer, F. M.; Chang, L. L. J. Org. Chem. 1972, 37, 1516
18. Wang, B.; Cerny, R. L.; Uppaluri, S.; Kempinger, J. J.; DiMagno, S. 
G. J. Fluorine Chem. 2010, 131, 1113
19. Wang, B.; Graskemper, J. W.; Qin, L.; DiMagno, S. G. Angew. Chem., 
Int. Ed. 2010, 49, 4079
20. Bordwell, F. G. Acc. Chem. Res. 1988, 21, 456
21. Christe, K. O.; Wilson, W. W.; Wilson, R. D.; Bau, R.; Feng, J. A. J. 
Am. Chem. Soc. 1990, 112, 7619
22. Cram, D. J.; Day, A. C. J. Org. Chem. 1966, 31, 1227
23. Krohn, K.; Rieger, H.; Hopf, H.; Barrett, D.; Jones, P. G.; Doering, 
D. Chem. Ber. 1990, 123, 1729
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atom at the 5-position, ortho-lithiation required installation 
of the diethylcarbamoyl directing group, as was reported 
previously.24, 25 (Direct lithiation of 4-methoxy-[2.2]paracy-
clophane was not successful in our hands; modeling indi-
cated that steric congestion forces the methyl group above 
the cyclophane ring, thereby aligning the oxygen lone pairs 
in an inappropriate geometry to coordinate an incoming 
organolithium reagent.) Transmetalation with zinc chlo-
ride was essential for successful introduction of the 4-me-
thoxyphenyliodonium diacetate moiety; the corresponding 
cyclophanyltributylstannane could not be coaxed to “trans-
metalate” with 4-methoxyphenyliodonium diacetate under 
any standard conditions.26
3(PF6) was converted to 3(F) by ion exchange with an-
hydrous TMAF in acetonitrile and desalted according to 
the procedure described previously for 2(F). 1H NMR spec-
tra of 3(F) in both acetonitrile and benzene showed no evi-
dence of aryl group exchange.
Thermal decomposition of 3(F) at 140 °C (15 min) gave a 
mixture of 4-fluoro- (72%) and 3-fluoroanisole (15%). Small 
amounts of inorganic silicon fluorides were also formed, 
presumably from the reaction of free fluoride or bifluoride 
with the borosilicate glass NMR tube. No fluorinated cy-
clophane was detected in the reaction mixture, supporting 
the hypothesis that aryne formation was largely responsi-
ble for the fluorocyclophanes observed during the thermal 
decomposition of 2(F), and confirming Chun and co-work-
ers’ observations that the methoxy group is not an effective 
ortho-director.27
In an attempt to gauge the temperature-dependence of 
the fluorination selectivity, thermolysis reactions of 3(F) 
were also conducted at 80 °C in benzene (6 h). Reactions 
run at this temperature were a bit more selective, but pro-
duction of 3-fluoroanisole could not be suppressed com-
pletely (Figure 4).
The generation of significant amounts of 3-fluoroan-
isole from the decomposition of 3(F) contrasts with the 
trace amounts formed under identical conditions from the 
symmetrical compound bis(4-methoxyphenyl)iodonium 
fluoride, 4(F). However, the more closely related, unsym-
metrically substituted iodonium salt, (2-methoxyphe-
nyl)(4-methoxyphenyl)iodonium fluoride, 5(F), provides 
2-fluoroanisole (59%), 3-fluoroanisole (15%), and 4-flu-
oroanisole (25%) at high temperature (benzene, 140 °C, 
15 min), and 2-fluoroanisole (65%), 3-fluoroanisole (9%), 
and 4-fluoroanisole (23%) at 80 °C. These results suggest 
that a methoxy group ortho to the I(III) center promotes 
aryne formation. Modeling (B3LYP/DGDZVP, ZPE, and 
thermal corrections) of the ground state structures of the 
4(F) and 5(F) along with the structures of the correspond-
ing diaryliodonium cations (Figure 5) indicates that an 
ortho methoxy substituent stabilizes an I(III) center to a 
greater extent than a para methoxy group and reduces the 
 
Table 1. Yieldsa of Reductive Elimination Products 
from 1(X) and 2(X) with Various Nucleophiles
         1(X)                          2(X)
X MeOPh-Xa Cyc-Xa   MeOPh-X Cyc-X
N3 86 14 96 0
SCN 81 18 92 0
OPh 51 40 84 0
SPh 43 52 82 0
OAc 68 31 51 0
OCH2CF3 19 39 42b (22+ 20) 37b (18 + 19)
F 7 73 37b (30 + 7) 55b (29 + 26)
a. All yields were determined by 1H NMR spectroscopy and 
confirmed by GC-MS. The products are functionalized anis-
oles (MeOPh-X) and functionalized paracyclophanes (Cyc-X).
b. Total amount of two different regioisomers. Numbers in 
parentheses refer to the total amount of expected and rear-
ranged functionalized product, respectively.
Figure 2. Thermal decomposition of [2.2]paracyclophane-substituted 
diaryliodonium fluorides 1(F) and 2(F).
Figure 3. Synthesis of 3(PF6).
24. Hopf, H.; Barrett, D. G. Liebigs Ann. 1995, 449
25. Wack, H.; France, S.; Hafez, A. M.; Drury, W. J., III; Weatherwax, 
A.; Lectka, T. J. Org. Chem. 2004, 69, 4531
26. Pike, V. W.; Butt, F.; Shah, A.; Widdowson, D. A. J. Chem. Soc., Per-
kin Trans. 1 1999, 245
27. Chun, J.-H.; Lu, S.; Lee, Y.-S.; Pike, V. W. J. Org. Chem. 2010, 75, 
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gas phase fluoride ion affinity of the I(III) by 1.52 kcal/
mol. Weaker I–F interactions should lead to an increase in 
fluoride ion basicity, leading, in turn, to a more accessible 
aryne pathway.
In summary, here we have demonstrated that cyclo-
phane-derived diaryliodonium salts bearing the electron-
rich 4-methoxyphenyl substituent can yield fluorinated 
anisoles exclusively. Previously, the 4-methoxyphenyl 
group was considered to be the “gold-standard” directing 
group for radiochemical fluorinations of diaryliodonium 
salts, and 4-fluoroanisole could not be obtained except in 
low yield from the symmetrical iodonium salt.12 The cy-
clophane ligand in 2(F) was shown to be resistant to fluo-
rination through a reductive elimination pathway, but the 
combination of cyclophane steric demand and electron do-
nation of the p-methoxy substituent enables easy access to 
a competing aryne fluorination pathway. Blocking of the 
position ortho to the I(III) center in 3(F) precludes cyclo-
phane aryne formation and results in exclusive fluorination 
of the anisole ring. The use of cyclophane as a directing 
group for I(III)-mediated fluorinations is a promising ap-
proach, particularly if highly electron-rich fluorinated aro-
matic compounds are the targets. Efforts are underway to 
streamline the synthesis of cyclophane-substituted diaryl-
iodonium salts to make these compounds more accessible.
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Supporting Information — Experimental procedures 
and analytical data for all new compounds and synthetic 
intermediates are presented in the following pages.
Figure 4. Thermal decomposition of 3(F).
Figure 5. Calculated (B3LYP/DGDZVP) optimized structures and rel-
ative energies of the (2-methoxyphenyl)4-methoxyphenyliodonium 
cation (top right), the bis(4-methoxyphenyl)iodonium cation (top left), 
4(F) (bottom left), and 5(F), bottom right.
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Materials: All materials were obtained from commercial sources and used as received unless 
otherwise noted. Zinc chloride was dried in vacuo before use. Tetramethylammonium fluoride 
(TMAF) was dried at 60-80 °C in a drying pistol (charged with P2O5) under dynamic vacuum for 
one week. Acetonitrile and acetonitrile-d3 were heated at reflux over P2O5, distilled into flame-
dried storage tubes and stored under dry nitrogen. Benzene and benzene-d6 were heated at reflux 
over CaH2 overnight and distilled directly into flame-dried storage tubes under dry nitrogen. 
Tetrahydrofuran (THF) was dried over Na/benzophenone and distilled into a flame dried storage 
flask under dry nitrogen. All glassware, syringes, and NMR tubes were oven dried (140 °C) for 
more than 24 h before they were transferred into the glove box for use. 1-(Diacetoxyiodo)-4-
methoxybenzene was synthesized according to our previously reported method.1 All NMR 
experiments reported here were performed using a Bruker Avance 400, 500, and 600 MHz NMR 
spectrometers in the NMR laboratory at the University of Nebraska-Lincoln. Yields from NMR 
scale reactions were determined by using the residual solvent peak as an internal standard. 
Reactions involving quantitative integration of fluorine NMR spectra were referenced to an add 
fluorotoluene standard. Additional product analyses were performed by GC-MS. 
 
Calculations:  All calculations were performed using the Gaussian2 suite of programs and 
visualization was performed with GaussView. Ground state geometries were identified after 
driving the C-C-I-H dihedral angle through a full range of motion. Structures were optimized and 
their energies calculated using DFT B3LYP/6-31G/DGDZVP methods. Frequency calculations 
on minimized structures were performed to make the zero point energy and thermal corrections. 
Transition states were optimized at the same computational level. 
 
 
Synthesis of cyclophanyliodonium salts:  
 
([2.2]Paracyclophan-4-yl)(4’-methoxyphenyl)iodonium hexafluorophosphate, 1(PF6) 
I
P
F
F F
F
F
F
MeO
 
 
In a 50 mL Schlenk tube under nitrogen, a stirred solution of bromocyclophane (1 mmol, 282 
mg) in 10 mL of anhydrous diethyl ether was cooled to -78 ºC. A solution of t-BuLi (1.7 M in 
pentane, 2.3 equiv.) was added dropwise and the resulting mixture was stirred at -78 ºC for 20 
minutes and then warmed to 0 ºC and allowed to stir for an additional 20 min. The reaction 
mixture was cooled again to -78 ºC before a solution of zinc chloride (200 mg, 1.5 mmol) in 
ether (10 mL) was added dropwise by cannula. After the addition, the reaction mixture was 
allowed to warm to room temperature over the course of one hour before the solvents were 
removed in vacuo. The remaining solid was dissolved in anhydrous CH3CN and the solution was 
cooled to -40 ºC and added dropwise to precooled (-40 ºC) suspension of bis(acetyloxy)-(4-
methoxyphenyl)-λ3–iodane (352 mg, 1 mmol) in 10 mL of acetonitrile. The mixture was allowed 
to warm to room temperature over 30 minutes before the solvent was removed in vacuo. The 
resulting solid was washed with hexanes and then dissolved in aqueous acetonitrile. Addition of 
an aqueous NaPF6 solution precipitated the product, which was extracted from the aqueous 
mixture with CH2Cl2. The organic layer was evaporated, dissolved in a minimal amount of 
S3 
CH2Cl2, precipitated with hexanes, filtered and dried in vacuo to yield 3 (225 mg, 38.4 % yield). 
1H NMR (CD3CN, 400 MHz, 25 °C): δ 8.00 (d, J = 9.1 Hz, 2 H), 7.27 (s, 1 H), 7.08 (d, J = 9.1 
Hz, 2 H), 6.83 (d, J = 7.7 Hz, 1 H), 6.76 (d, J = 7.7 Hz, 1 H), 6.65 (s (broad), 2 H), 6.38 (d, J = 
7.9 Hz, 1 H), 6.31 (d, J = 7.9 Hz, 1 H), 3.84 (s, 3 H), 3.04-3.35 (m, 8 H); 13C NMR (CD3CN, 100 
MHz, 25 °C) δ 164.1, 143.2, 140.9, 139.8, 139.4, 139.2, 138.8, 137.6, 134.3, 134.2, 133.7, 132.4, 
120.9, 119.4, 100.8, 56.7, 38.4, 35.6, 35.4, 35.3; HRMS: (HRFAB) calcd. for C23H22OI [M]+ 
441.07098, found 441.0712. 
 
Fluorination 1(PF6): In a N2 charged glove box, 11.7 mg 1(PF6) (0.02 mmol) was dissolved in 
0.3 mL of dry acetonitrile, to which a solution of 1 mg anhydrous TMAF (1 equivalent ) in 0.3 
mL of dry acetonitrile was added dropwise. The combined solution was transferred into a 
Schlenk flask, sealed and taken out of the glove box. Solvent was evaporated, and the remainder 
was taken back into the glove box and redissolved in 0.6 mL of d6-benzene, passed through a 0.2 
μm PTFE syringe filter, and transferred into a J-Young NMR tube. The tube was sealed, taken 
out of the box, and heated in a 140 °C oil bath for 15 minutes. Yields of fluorinated arenes were 
determined by 1H and 19F NMR spectroscopy and confirmed by GC-MS. 4-Fluoro-
[2.2]paracyclophane was formed in  73% yield, 4-fluoroanisole was formed in 7% yield; 3-
fluoroanisole was detectable in GC-MS but barely shows up in 19F NMR spectrum, the 
remaining fluoride was incorporated in fluorosilicates and fluoroborates, presumably arising 
from the reaction of generated HF acting upon the borosilicate NMR tube. 
(7-Methoxy[2.2]paracyclophan-4-yl)(4’-methoxyphenyl)iodonium hexafluorophosphate, 
2(PF6) 
 
In a 100 mL Schlenk tube, 4-methoxy-7-bromo[2.2]paracyclophane (1.26 mmol, 400.6 mg) was 
dissolved in 25 mL of distilled ether and cooled to -78 °C. To the cooled solution, 1.7M t-butyl 
lithium (3.16 mmol, 1.85 mL) was added dropwise and the stirred solution was held at -78 °C for 
1 hour.  A solution of anhydrous zinc chloride (1.51 mmol, 206.1 mg) in 10 mL of diethyl ether 
was added dropwise to the cooled solution. The mixture was allowed to warm to room 
temperature, and the solvent was removed under reduced pressure. The residual solid 
(organozinc chloride reagent and lithium salts) was taken up in anhydrous acetonitrile and cooled 
to -40 °C before a solution of 4-methoxy(diacetoxyiodo)benzene (1.89 mmol, 665.5 mg) in 
acetonitrile (10 mL) was added in a dropwise fashion. After 1 hour at -40 °C, the mixture was 
warmed to room temperature and the solvent was removed under reduced pressure. Deionized 
water and sodium hexafluorophosphate (410 mg) were added, followed by 50 mL of 
dichloromethane. The mixture was transferred to a separatory funnel and the organic phase was 
separated. The solvent was removed by rotary evaporation and the remaining solid was dissolved 
in 5 mL of dichloromethane and dripped into 150 mL hexanes. The precipitate was aged for one 
hour, collected by gravity filtration, and dried in vacuo to yield a colorless salt (55.6 %, 431.7 
mg). 1H NMR (CD3CN, 400 MHz, 25 °C): δ 8.01 (d, J = 9.2 Hz, 2 H), 7.25 (s, 1 H), 7.07 (d, J = 
9.2 Hz, 2 H), 6.81 (dd, J = 7.8, 1.8 Hz, 1 H), 6.62 (dd, J = 7.9, 1.9 Hz, 1 H), 6.29 (dd, J = 7.9, 1.6 
Hz, 1 H), 6.12 (dd, J = 8.0, 2.0 Hz, 1 H), 6.02 (s, 1 H), 3.83 (s, 3 H), 3.74 (s, 3 H), 3.31 (ddd, J = 
S4 
11.6, 9.8, 1.7 Hz, 1 H), 3.26 (dd, J = 8.4, 5.7 Hz, 1 H), 3.23 (dd, J = 13.9, 4.3 Hz, 1 H), 3.18 (dd, 
J = 12.9, 4.1 Hz, 1 H), 3.15 (dd, J = 8.3, 3.0 Hz, 1 H), 3.05 (ddd, J = 12.8, 9.9, 6.4 Hz, 1 H), 3.02 
(ddd, J = 12.8, 9.9, 6.4 Hz, 1 H), 2.68 (ddd, J = 13.1, 10.5, 6.4 Hz, 1 H). 13C NMR (CD3CN, 100 
MHz, 25 °C): δ 163.3, 161.6, 146.4, 140.5, 139.9, 137.9, 137.4, 133.2, 132.4, 131.4, 131.3, 
128.8, 119.8, 118.2, 107.4, 101.1, 55.8, 54.9, 37.2, 34.5, 32.9, 30.7. 19F NMR (CD3CN, 376 
MHz, 25 °C): δ -72.7 (d, J = 706.7 Hz, 6 F). HRMS: (HRFAB) calcd. for C24H24IO2 [M]+ 
471.08210, 472.08454; found 471.08221, 472.08561. 
Fluorination of 2(PF6): In a N2 charged glove box, 12.3 mg 2(PF6)  (0.02 mmol) was dissolved 
in 0.3 mL of dry acetonitrile, to which a solution of 1 mg anhydrous TMAF (1 equivalent ) in 0.3 
mL of dry acetonitrile was added dropwise. The solvent was evaporated, and the remainder was 
dissolved in 0.6 mL of d6-benzene, passed through a 0.2 μm PTFE syringe filter, and transferred 
into a J-Young NMR tube. The tube was sealed, taken out of the box, and heated in a 140 °C oil 
bath for 15 minutes*. Yields of fluorinated arenes were determined by 1H and 19F NMR 
spectroscopy and confirmed by GC-MS. 4-fluoro-7-methoxy[2.2]paracyclophane in 26% yield, 
4-fluoro-8-methoxy[2,2]paracyclophane in 29% yield (in GC-MS, these two fluorocyclophane 
species appear to be equal amount), 4-fluoroanisole was formed in 30% yield, 3-fluoroanisole in 
6.5% yield, the rest of the fluoride ended up as unidentified inorganic species (singlets in 19F 
NMR). 
Decomposition was also performed at 80 °C, the reaction took 3 hours to finish, and the product 
ratios were similar to the reaction done at 140 °C.  
(5-Methoxy[2.2]paracyclophan-4-yl)(4-methoxyphenyl)iodonium hexafluorophosphate, 
3(PF6) 
 
In a 100 mL Schlenk tube, 4-methoxy-5-iodo-[2.2]paracyclophane (416.7 mg, 1.14 mmol) was 
dissolved in 25 mL of distilled Et2O and cooled to -78 °C. To this stirred solution, 1.7 M t-butyl 
lithium (1.68 mL, 2.85 mmol) was added dropwise and the solution was held at -78 °C for 1 h. A 
solution of anhydrous zinc chloride (1.37 mmol, 190.0 mg) in 10 mL of Et2O was added 
dropwise to the cold solution over the course of 1 h. The mixture was allowed to warm to room 
temperature, and the solvent was removed under reduced pressure. The residual solid 
(comprising organozinc chloride reagent and lithium salts) was taken up in anhydrous 
acetonitrile and cooled to -40 °C before a solution of 4-methoxyphenyliodonium diacetate (1.89 
mmol, 665.5 mg) in acetonitrile (10 mL) was added in a dropwise fashion. The mixture was held 
at -40 °C for 1 h and allowed to warm to room temperature. The solvent was removed under 
reduced pressure, and, in order, deionized water, sodium hexafluorophosphate (470 mg), and 50 
mL of CH2Cl2 were added. The mixture was transferred to a separatory funnel and the organic 
phase was separated. The solvent was removed by rotary evaporation and the remaining solid 
was dissolved in 5 mL of dichloromethane and dripped into 150 mL hexanes. The precipitate 
was aged for 1 h, collected by gravity filtration, and dried in vacuo to yield a colorless salt (91.0 
mg, 13.0 %). 1H NMR (CD3CN, 400 MHz, 25 °C): δ 7.99 (d, 9.3 Hz, 2H), 7.07 (d, 9.2 Hz, 2H), 
S5 
6.84 (d, 7.8 Hz, 1H), 6.59- 6.69 (m, 4H), 6.11 (d, 7.9 Hz, 1H), 3.88 (s, 3H), 3.84 (s, 3H), 3.32 – 
3.38 (m, 1H), 3.06 – 3.26 (m, 6H), 2.93 – 3.00 (m, 1H). 13C NMR (CD3CN, 400 MHz, 25 °C): δ 
163.4, 156.9, 144.9, 142.3, 140.0, 138.3, 138.2, 133.7, 133.3, 133.2, 131.8, 130.4, 129.2, 118.3, 
99.3, 62.5, 55.8, 36.9, 33.8, 33.7, 31.9. 19F NMR (CD3CN, 400 MHz, 25 °C): δ -72.8 (d, J = 
706.9 Hz, 6F). HRMS: (HRFAB) calcd. for C24H24IO2 [M]+ 471.0821, found 471.0806. 
Fluorination of 3(PF6): In a N2 charged glove box, 12.3 mg 3(PF6)  (0.02 mmol) was dissolved 
in 0.3 mL of dry acetonitrile, to which a solution of 1 mg anhydrous TMAF (1 equivalent ) in 0.3 
mL of dry acetonitrile was added dropwise. The solvent was evaporated, and the remainder was 
dissolved in 0.6 mL of d6-benzene, passed through a 0.2 μm PTFE syringe filter, and transferred 
into a J-Young NMR tube. The tube was sealed, taken out of the box, and heated in a 140 °C oil 
bath for 15 minutes*. Yields of fluorinated arenes were determined by 1H and 19F NMR 
spectroscopy and confirmed by GC-MS. 4-fluoroanisole was formed in 72 % yield, 3-
fluoroanisole in 15 % yield, the rest of the fluoride ended up as unidentified inorganic species 
(singlet at -128.1 ppm and multiplets at -130.7 ppm in 19F NMR). 
For this salt, decomposition was also performed at 80 °C, the reaction took 6 hours to finish and 
4-fluoroanisole was formed in 81 % yield, 3-fluoroanisole in 9 % yield. (Unidentified inorganic 
species were also present.) 
Synthesis of model diaryliodonium salts: 
Bis(4-methoxyphenyl)iodonium hexafluorophosphate, 4(PF6) 
I OMeMeO
PF
F F
F
F
F
 
In a glove box under nitrogen, 1-(diacetoxyiodo)-4-methoxybenzene (352 mg, 1 mmol) was 
weighed into a glass vial and 1.5 mL of dry acetonitrile was added. A solution containing p-
toluenesulfonic acid monohydrate (190 mg, 1 mmol) dissolved in 1.5 mL of dry acetonitrile was 
added by syringe. Upon completion of the addition, 4-iodoanisole (neat, 0.11 mL, 1 mmol) was 
added and the vial was sealed and taken out of the glove box; the mixture was allowed to stir at 
room temperature for 2 h. Water (10 mL) was added and the mixture was transferred to a 
separatory funnel and extracted (3 × 5 mL) with hexanes. The reserved aqueous layer was treated 
with 502 mg (3 mmol) of NaPF6. The white precipitate was filtered, dried in vacuo, and 
recrystallized in a mixture of diethyl ether/dichloromethane to give 391 mg of bis(4-
methoxyphenyl)iodonium hexafluorophosphate (80.5%). 1H NMR (CD3CN, 400 MHz, 25 °C): δ 
7.973 (d, J = 9.1 Hz, 4H, H2/H2’/H6/H6’), 7.046 (d, J = 9.1 Hz, 4H, H3/H3’/H5/H5’), 3.833 (s, 
6H, OMe); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 164.61 (C4/C4’), 138.55 (C2/C2’/C6/C6’), 
119.42 (C3/C3’/C5/C5’), 103.36 (C1/C1’), 57.06 (OMe); 19F NMR (CD3CN, 376 MHz, 25 °C) δ 
-72.833 (d, 1JP-F = 707.3 Hz, PF6-); HRMS (HRFAB): calcd. for C14H14O2I [M – PF6]+ 341.0038 
found 341.0036. 
 (2-Methoxyphenyl)(4-methoxyphenyl)iodonium hexafluorophosphate 5(PF6) 
S6 
IMeO
P
F
F F
F
F
F
MeO  
In a glove box under nitrogen, 1-(diacetoxyiodo)-2-methoxybenzene (352 mg, 1 mmol) was 
weighed into a glass vial and 1.5 mL of dry acetonitrile was added. A solution containing p-
toluenesulfonic acid monohydrate (190 mg, 1 mmol) dissolved in 1.5 mL of dry acetonitrile was 
added by syringe. Upon completion of the addition, 4-iodoanisole (neat, 0.11 mL, 1 mmol) was 
added. The vial was sealed and taken out of the glove box; the mixture was allowed to stir at 
room temperature for 2 h. Water (10 mL) was added and the mixture was transferred to a 
separatory funnel and extracted (3 × 5 mL) with hexanes. The reserved aqueous layer was treated 
with 502 mg (3 mmol) of NaPF6. The white precipitate was filtered, dried in vacuo, and 
recrystallized in a mixture of diethyl ether/dichloromethane to give 405 mg (83.3%) of (2-
methoxyphenyl)-(4’-methoxyphenyl)iodonium hexafluorophosphate. 1H NMR (CD3CN, 400 
MHz, 25 °C): δ 7.988 (d, J = 9.2 Hz, 2H, H2’/H6’), 7.878 (d, J =8.4 Hz, 1H, H6), 7.659 (td, J1 = 
8.4 Hz, J2 = 1.3 Hz,1H, H4), 7.232 (dd, J1 = 8.4 Hz, J2 = 1.3 Hz, 1H, H5), 7.063 (td, J1 =  8.4 Hz, 
J2 = 1.3 Hz, 1H, H3), 7.051 (d, J = 9.2, 2H, H3’/H5’), 3.970 (s, 3H, 2-OMe), 3.841 (s, 3H, 4’-
OMe); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 164.73 (C4’), 157.90 (C2), 139.52 (C2’/C6’), 
137.08 (C4), 136.79 (C6), 125.36 (C3), 119.44 (C3’/C5’), 114.70 (C5), 104.69 (C1), 100.92 
(C1’), 58.40 (2-OMe), 57.06 (4’-OMe); 19F NMR (CD3CN, 376 MHz, 25 °C) δ -72.675 (d, 1JP-F 
= 706.2 Hz, PF6-); HRMS (HRFAB): calcd. for C14H14O2I [M – PF6]+ 341.0038 found 341.0035. 
 
Synthesis of precursors: 
Bis(acetyloxy)-(4-methoxyphenyl)-λ3–iodane; (1-(diacetoxyiodo)-4-methoxybenzene 
I OAcAcO
OCH3  
4-Iodoanisole (2.34 g, 10 mmol) was dissolved in 90 mL of glacial acetic acid and the stirred 
solution was warmed to 40 °C. Sodium perborate tetrahydrate (13.6 g, 110 mmol) was added in 
portions over the course of one hour. After the addition was complete, the temperature of the 
reaction mixture was maintained at 40 °C for 8 h before it was allowed to cool to room 
temperature. Half of the acetic acid (~ 45 mL) was removed by distillation at reduced pressure. 
The remaining solution was treated with 100 mL of deionized water and the aqueous layer was 
extracted (3 × 40 mL) with dichloromethane. The combined organic fractions were dried over 
sodium sulfate, and the solvent was removed by rotary evaporation to give 2.25 g (64%) of 1-
(diacetoxyiodo)-4-methoxybenzene, 1a. This compound was dried in vacuo and used without 
further purification. 1H NMR (CD3CN, 400 MHz, 25 °C): δ 8.055 (d, J = 9.1 Hz, 2H, H2/H6), 
7.053 (d, J = 9.1 Hz, 2H, H3/H5), 3.861 (s, 3H, OMe), 1.905 (s, 6H, (OCOCH3)2); 13C NMR 
(CD3CN, 100 MHz, 25 °C) δ 177.73 (CO), 163.73 (C4), 138.75 (C2/C6), 118.00, (C3/C5), 
111.97 (C1), 56.85 (OMe), 20.76 ((OCOCH3)2); HRMS: (HRFAB) calcd. for C14H13NO4I [M – 
2OAc+3-NBA]+ 385.9889 found 385.9885. (lit. 3,4 13C NMR (CDCl3, 50 MHz, 20 °C) δ 162.0 
S7 
(C4), 137.0 (C2/C6), 116.5 (C3/C5), 111.4 (C1).); 13C NMR (CDCl3, 75 MHz, 25 °C) δ 176.31 
(CO), 111.64 (C1), 20.36 ((OCOCH3)2).) 
Bis(acetyloxy)-(2-methoxyphenyl)-λ3–iodane; (1-(diacetoxyiodo)-2-methoxybenzene 
I OAcAcO
O
CH3
 
2-Iodoanisole (2.34 g, 10 mmol) was dissolved in 90 mL of glacial acetic acid and the stirred 
solution was warmed to 40 °C. Sodium perborate tetrahydrate (13.6 g, 110 mmol) was added in 
portions over the course of one hour. After the addition was complete, the temperature of the 
reaction mixture was maintained at 40 °C for 8 h before it was allowed to cool to room 
temperature. Half of the acetic acid (~ 45 mL) was removed by distillation at reduced pressure. 
The remaining solution was treated with 100 mL of deionized water and the aqueous layer was 
extracted (3 × 40 mL) with dichloromethane. The combined organic fractions were dried over 
sodium sulfate, and the solvent was removed by rotary evaporation to give 2.29 g (65%) of 1-
(diacetoxyiodo)-2-methoxybenzene. This compound was dried in vacuo and used without further 
purification. 1H NMR (CD3CN, 400 MHz, 25 °C): δ 8.175 (d, J = 8.0 Hz, 1H, H6), 7.690 (dd, J1 
= 7.6, J2= 8.2 Hz 1H, H5), 7.313 (d, J =8.2 Hz, 1H, H3), 7.085 (dd, J1 =8.0, J2=7.6 Hz, 1H, H4), 
3.958 (s, 3H, OMe), 1.884(s, 6H, (OCOCH3)2); 13C NMR (CD3CN, 100 MHz, 25 °C) δ 178.00 
(CO), 157.72(C2), 139.09 (C6), 136.34 (C4), 124.17 (C3), 113.91 (C1), 113.87 (C5), 58.20 
(OMe), 20.71((OCOCH3)2); HRMS (HRFAB): calcd. for C14H13NO4I [M – 2OAc+3-NBA]+ 
385.9889 found 385.9874. (lit.5 1H NMR δ (270 MHz, CDCl3) 8.10 (1H, d, H6 J = 8 Hz), 7.56 
(1H, t, H5 J = 8 Hz), 7.13 (1H, d, H3, J = 8 Hz), 7.00 (1H, t, H4 J = 8 Hz), 3.95 (3H, s, OCH3), 
1.93 (6H, s, (OCOCH3)2); 13C NMR (68 MHz; CDCl3) δ 176.7 (CO), 156.3 (C3), 137.8, 134.6, 
122.9, 113.4 (C1), 112.1, 57.0 (OMe), 20.5 ((OCOCH3)2).) 
 
4-Bromo-[2.2]paracyclophane,6 6 
 
N-Bromosuccinimide (890.1 mg, 5.0 mmol) and trifluoroacetic acid (570 mg, 0.385 mL, 5.0 
mmol) were dissolved in 40 mL of dichloromethane and added to a CH2Cl2 solution (80 mL) of 
[2.2]paracyclophane (1.0297 g, 4.9 mmol). The resulting mixture was covered from light and 
stirred for 4 hours at room temperature. The solution was transferred to a separatory funnel and 
washed (3 x 50 mL) with 2 M aqueous sodium bicarbonate solution followed by a single 
deionized water wash. The organic layer was separated, dried over Na2SO4, and the solvent was 
evaporated to give a nearly colorless solid (1.061 g, 75 %) that was sufficiently pure to carry 
forward in the synthesis. 1H NMR (CDCl3, 400 MHz, 25 °C): δ 7.18 (dd, J = 7.8, 1.9 Hz, 1 H), 
6.45-6.61 (m, 6 H), 3.45-3.52 (m, 1 H), 2.80-3.26 (m, 7 H); 13C NMR (CDCl3, 100 MHz, 25 °C) 
δ 141.61, 139.33, 139.11, 137.25, 135.05, 133.31, 133.02, 132.91, 132.25, 131.46, 128.69, 
126.97, 35.85, 35.48, 34.82, 33.47. 
 
S8 
4-Hydroxy[2.2]paracyclophane,7 7 
HO
 
In a 50 mL Schlenk tube under nitrogen, a stirred, cold (-78 ºC) solution of 4-
bromo[2.2]paracyclophane (4.0 mmol, 1.14 g) in 50 mL of anhydrous diethyl ether was treated 
with t-BuLi (1.7 M in pentane, 2.5 equiv., added dropwise). The resulting mixture was stirred at -
78 ºC for 20 min and held subsequently at 0 ºC for 20 min. To this heterogeneous yellow mixture 
trimethyl borate (0.89 mL, 8.0 mmol) was added dropwise by syringe and the mixture was stirred 
for 1 h at room temperature. During this period the solution became homogeneous and dark 
yellow. When the reaction was quenched with aqueous NaOH (0.5 M, 2 mL) and H2O2 (30%, 
1.5 mL), a slight exotherm and gas evolution were noted. The resulting mixture was allowed to 
stir overnight at room temperature. Additional aqueous NaOH solution (0.5 M, 5 mL) was added 
and the pH of the solution was adjusted to neutral using saturated sodium bicarbonate solution 
and 1 M HCl. The mixture was extracted (3 × 20 mL) with diethyl ether. The combined ether 
extracts were washed with 0.5 M sodium bisulfite, and the organic layers was separated and 
dried over Na2SO4. Removal of the solvent by rotary evaporation gave a light brown solid (844.1 
mg, 94.1%). 1H NMR (CDCl3, 400 MHz, 25 °C): δ 7.01 (dd, J = 7.8, 1.9 Hz, 1 H), 6.56 (dd, J = 
7.8, 1.9 Hz, 1 H), 6.46 (dd, J = 7.8, 1.9 Hz, 1 H), 6.38-6.42 (m, 2 H), 6.27 (dd, J = 7.7, 1.6 Hz, 1 
H), 5.55 (d, J = 1.6 Hz, 1 H), 3.29-3.39 (m, 1 H), 2.87-3.16 (m, 6 H), 2.62-2.73 (m, 1 H). 13C 
NMR (CDCl3, 100 MHz, 25 °C): δ 153.7, 142.0, 139.6, 138.8, 135.5, 133.0, 132.8, 131.9, 127.9, 
125.4, 125.0, 122.6, 35.3, 34.8, 33.8, 31.1. 
4-Methoxy[2.2]paracyclophane,6 8 
 
In a 100 mL glass tube sealed with a Teflon screw cap closure, potassium carbonate (1.66 g, 12 
mmol) and 4-hydroxy[2.2]paracyclophane (869.6 mg, 3.87 mmol) were heated to 80 ºC in 60 mL 
of acetonitrile for 30 minutes. Iodomethane (1.7 g, 12 mmol) was added to the mixture, the 
storage tube was sealed, and the stirred solution was heated at 80 ºC for 3 days. The solvent was 
removed by rotary evaporation and the remaining solid was treated with ethyl acetate and water 
and transferred to a separatory funnel. The aqueous layer was neutralized with 0.1 M HCl 
solution, the mixture was shaken, and the organic layer was separated and dried over Na2SO4. 
Rotary evaporation of solvent yielded a nearly colorless solid. The somewhat insoluble material 
was dissolved in hot hexanes and purified via column chromatography (60 Å silica gel, hexanes, 
Rf = 0.28) to afford a colorless solid (602.4 mg, 65.4 %).  1H NMR (CDCl3, 400 MHz, 25 °C): δ 
6.76 (dd, J = 7.8, 1.8 Hz, 1 H), 6.38 – 6.55 (m, 4 H), 6.28 (dd, J = 7.5, 1.4 Hz, 1 H), 5.67 (d, J = 
1.3,  1 H), 3.71 (s, 3 H), 3.42 – 3.48 (m, 1 H), 2.99 – 3.13 (m, 6 H), 2.59 – 2.66 (m, 1 H). 13C 
NMR (CDCl3, 100 MHz, 25 °C): δ 157.6, 142.1, 140.3, 138.8, 135.0, 133.7, 133.1, 131.5, 128.4, 
127.5, 124.4, 116.7, 54.3, 35.5, 35.4, 34.1, 31.7. 
 
S9 
4-Methoxy-7-bromo[2.2]paracyclophane,8 9 
MeO Br
 
To a solution of 4-methoxy[2.2]paracyclophane (349.7 g, 1.47 mmol) in 30 mL CH2Cl2, was 
added N-bromosuccinimide (279.4 mg, 1.57 mmol) and trifluoroacetic acid (179.0 mg, 0.12 mL, 
1.57 mmol) dissolved in 15 mL of CH2Cl2. The resulting mixture was covered from light and 
stirred for 30 minutes at room temperature. The solution was transferred to a separatory funnel 
and washed (3 x 50 mL) with 2 M aqueous sodium bicarbonate solution followed by deionized 
water. The organic layer was separated, dried over Na2SO4, and the solvent was evaporated. The 
resulted light brown solid was purified by column chromatography (60 Å silica gel, hexanes) to  
give the product as a pale yellow solid (400.6 mg, 86 %). 1H NMR (CDCl3, 400 MHz, 25 °C): δ 
7.10 (dd, J = 7.8, 1.8 Hz, 1 H), 6.76 (dd, J = 7.9, 1.9 Hz, 1 H), 6.41 - 6.46 (m, 3 H), 5.69 (s, 1 H), 
3.71 (s, 3 H), 3.34 - 3.45 (m, 2 H), 3.18 - 3.25 (m, 1 H), 2.98 – 3.10 (m, 3 H), 2.71 – 2.78 (m, 1 
H), 2.46 – 2.54 (m, 1 H); 13C NMR (CDCl3, 100 MHz, 25 °C) δ 157.15, 140.81, 139.95, 138.76, 
138.65, 133.19, 133.16, 131.83, 130.00, 129.19, 118.54, 117.26, 54.69, 35.89, 33.82, 33.51, 
31.29. 
 
4-Diethylcarbamoyl[2.2]paracyclophane,9 10 
O
O
N
 
In a 250 mL Schlenk flask, a solution of 4-hydroxy[2.2]paracyclophane (644.9 mg, 2.88 mmol) 
in 50 mL of anhydrous toluene was treated with 4-(dimethylamino)pyridine (DMAP) (703.7 mg, 
5.76 mmol) and diethylcarbamoyl chloride (0.73 mL, 5.76 mmol). The resulting mixture was 
stirred and heated at reflux for 7 h, while the progress of the reaction was monitored by TLC 
(silica gel, dichloromethane). The reaction was cooled to room temperature, hydrolyzed with 50 
mL of deionized water, and extracted (3 × 35 mL) with dichloromethane. The combined organic 
extracts were dried over Na2SO4. The solvent was removed by rotary evaporation, and the raw 
product was purified by column chromatography (silica gel, dichloromethane) to afford a 
colorless crystalline solid (698.9 mg, 75%). 1H NMR (CDCl3, 400 MHz, 25 °C): δ 6.85 (dd, J = 
7.8, 1.3 Hz, 1 H), 6.41-6.57 (m, 5 H), 6.12 (d, J = 1.3 Hz, 1 H), 3.66 (q, br, 2 H), 3.40 (q, br, 2 
H), 3.25 (m, 1 H), 3.05, (m, 6 H), 2.73 (m, 1 H), 1.42 (t, br, 3 H), 1.22 (t, br, 3 H) 13C NMR 
(CDCl3, 100 MHz, 25 °C): δ 153.7, 149.5, 141.3, 139.5, 139.3, 135.1, 133.4, 133.0, 132.2, 131.1, 
129.5, 129.4, 128.6, 42.2, 41.9, 35.3, 34.9, 34.6, 31.7, 14.5, 13.5. 
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4-Diethylcarbamoyl-5-iodo[2.2]paracyclophane,10 11 
O
O
N I
 
In a 250 mL Schlenk tube, a solution of O-(4-[2.2]paracyclophanyl) diethylcarbamate (698.9 mg, 
2.16 mmol) in 55 mL of anhydrous tetrahydrofuran (THF) was treated with 
tetramethylethyldiamine (TMEDA) (0.39 mL, 2.6 mmol) and cooled to -78 °C. The resulting 
mixture was treated with sec-butyllithium (1.4 M in cyclohexane, 1.1 mL, 2.9 mmol, drop wise) 
and stirred at -78 °C for 2 h. The reaction mixture became clear yellow. After 2 h, a solution of 
diiodoethane (1.83 g, 6.48 mmol) in anhydrous THF was added drop wise to the reaction 
mixture, and the solution was allowed to warm slowly to room temperature overnight. After 15 
h, the solution had turned dark purple. The THF was removed in vacuo and the residue was 
dissolved in 55 mL of Et2O and 55 mL of aqueous 5% sodium thiosulfate. The organic layer was 
washed with an additional 55 mL of aqueous 5% sodium thiosulfate. The aqueous phase was 
extracted with Et2O (3 × 20 mL). The organic layers were combined, washed with 20 mL of 1 M 
HCl, separated, and dried over Na2SO4. The solvent was evaporated to afford an off-white 
crystalline solid (949.2 mg, 98%). 1H NMR (CDCl3, 400 MHz, 25 °C): δ 7.14 (d, J = 8.0 Hz, 1 
H), 6.67 (d, J = 7.3 Hz, 1 H), 6.52 – 6.60 (m, 3 H), 6.45 (d, J = 7.8 Hz, 1 H), 3.77 – 3.85 (m, 1 
H), 3.52 – 3.61 (m, 1 H), 3.35 – 3.47 (m, 3H), 2.97 – 3.21 (m, 6 H), 2.78 – 2.86 (m, 1 H), 1.50 (t, 
J = 7.1 Hz, 3 H), 1.23 (t, J = 7.1 Hz, 3 H). 13C NMR (CDCl3, 100 MHz, 25 °C): δ 152.6, 149.1, 
145.3, 139.1, 138.6, 134.4, 133.3, 132.9, 132.9, 130.6, 128.9, 128.6, 103.6, 42.4, 42.1, 39.2, 34.5, 
33.0, 31.8, 14.7, 13.4. 
 
4-Hydroxy-5-iodo[2.2]paracyclophane,10 12 
 
In a 50 mL round bottom flask, O-[4-(5-iodo-[2.2]paracyclophanyl)] diethylcarbamate (930.8 
mg, 2.07 mmol) and potassium hydroxide (2.90 g, 51.75 mmol) were suspended in 15 mL of 
ethylene glycol. Hydrazine (331.7 mg, 10.35 mmol) was added and the mixture was heated at 
reflux for 2 h. During the reflux period, the mixture became homogenous. The solution was 
cooled to room temperature, transferred to a separatory funnel, acidified to pH 1 with 1 M HCl, 
and diluted with deionized water. The aqueous phase was extracted with Et2O (4 × 40 mL). The 
organic layers were combined, dried over Na2SO4, and solvent was removed in vacuo to afford 
an off-white solid (550.2 mg, 78%). 1H NMR (CDCl3, 400 MHz, 25 °C): δ 7.04 (dd, J = 7.8, 1.5 
Hz, 1 H), 6.78 (dd, J = 7.8, 1.5 Hz, 1 H), 6.47 – 6.57 (m, 3 H), 6.27 (d, J = 7.6 Hz, 1H), 5.12 (s, 1 
H), 3.38 – 3.44 (m, 1 H), 3.25 – 3.33 (m, 1 H), 2.96 – 3.15 (m, 5 H), 2.69 – 2.76 (m, 1 H). 13C 
NMR (CDCl3, 100 MHz, 25 °C): δ 152.3, 144.5, 139.7, 137.7, 134.9, 133.1, 133.0, 128.1, 127.3, 
126.2, 125.6, 99.5, 39.3, 34.0, 32.9, 31.5. 
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4-Methoxy-5-iodo[2.2]paracyclophane,10 13 
 
In a 100 mL glass tube sealed with a Teflon screw cap closure, potassium carbonate (992.3 mg, 
7.18 mmol) and 4-hydroxy-5-iodo[2.2]paracyclophane (548.3 mg, 1.56 mmol) were heated to 70 
ºC in 15 mL of acetone for 30 min. Iodomethane (553.6 mg, 3.90 mmol) was added to the 
mixture, the tube was re-sealed, and the stirred solution was heated at 70 ºC for 24 h. The 
mixture was transferred to a round bottom flask, the solvent was removed by rotary evaporation. 
The remaining solid was treated with 15 mL of deionized water and 15 mL of dichloromethane 
and transferred to a separatory funnel. The aqueous layer was extracted with dichloromethane (3 
× 30 mL), the organic layers were combined, dried over Na2SO4, and the solvent was removed in 
vacuo to yield pale yellow oil. This crude product was purified by column chromatography (60 Å 
silica, 10% EtOAc/hexanes) to afford the pure product as a white solid (416.7 mg, 73%). 1H 
NMR (CDCl3, 400 MHz, 25 °C): δ 7.09 (d, J = 7.9 Hz, 1 H), 6.70 (d, J = 7.9 Hz, 1 H), 6.53 (d, J 
= 7.7 Hz, 1 H), 6.52 (s, 2 H), 6.35 (d, J = 7.7 Hz, 1 H), 3.64 (s, 3 H), 3.38 – 3.43 (m, 1 H), 3.26 – 
3.33 (m, 1 H), 3.08 – 3.19 (m, 2 H), 2.92 – 3.03 (m, 3 H), 2.74 – 2.81 (m, 1 H). 13C NMR 
(CDCl3, 100 MHz, 25 °C): δ 157.7, 145.6, 139.4, 138.4, 135.2, 132.8, 132.7, 131.8, 129.4, 128.9, 
128.7, 103.5, 60.9, 39.2, 34.5, 33.0, 31.2. 
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Figure S1. 1H NMR spectrum of 4-bromo[2.2]paracyclophane in CDCl3.
S13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. 13C NMR spectrum of 4-bromo[2.2]paracyclophane in CDCl3.
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Figure S3. 1N NMR spectrum of 4-hydroxy[2.2]paracyclophane in CDCl3.
S15 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4. 13C NMR spectrum of 4-hydroxy[2.2]paracyclophane in CDCl3. 
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Figure S5. 1H NMR spectrum of 4-methoxy[2.2]paracyclophane in CDCl3. 
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Figure S6. 13C NMR spectrum of 4-methoxy[2.2]paracyclophane in CDCl3.
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Figure S7. 1H NMR spectrum of 4-methoxy-7-iodo[2.2]paracyclophane in CD2Cl2.
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Figure S8. 13C NMR spectrum of 4-methoxy-7-iodo[2.2]paracyclophane in CD2Cl2.
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Figure S9. 1H NMR spectrum of 4-methoxy-7-bromo[2.2]paracyclophane in CDCl3.
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Figure S10. 13C NMR spectrum of 4-methoxy-7-bromo[2.2]paracyclophane in CDCl3.
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Figure S11. HSQC NMR spectrum (detail) of 4-methoxy-7-bromo[2.2]paracyclophane in CDCl3.
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Figure S12. HSQC NMR spectrum (detail) of 4-methoxy-7-bromo[2.2]paracyclophane in CDCl3.
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Figure S13. 1H and 13C NMR spectra of 1(PF6) in CD3CN.
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Figure S14. HSQC NMR spectrum of 1(PF6) in CD3CN.
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Figure S15. 1H and 13C NMR spectra of 2(PF6) in CD3CN.
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Figure S16. HSQC NMR spectrum (detail) of 2(PF6) in CD3CN.
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Figure S17. HSQC NMR spectrum (detail) of 2(PF6) in CD3CN.
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Figure S18. HSQC-HMBC NMR spectrum of 2(PF6) in CD3CN.
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Figure S19. 1H-1H COSY NMR spectrum of 2(PF6) in CD3CN.
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Figure S20. 1H-1H NOESY NMR spectrum of 2(PF6) in CD3CN.
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Figure S21. 1H-1H NOESY NMR spectrum (detail) of 2(PF6) in CD3CN.
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Figure S22. 1H NMR spectrum of 4-diethylcarbamoyl[2.2]paracyclophane in CDCl3.
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Figure S23. 13C NMR spectrum of 4-diethylcarbamoyl[2.2]paracyclophane in CDCl3.
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Figure S24. 1H NMR spectrum of 4-diethylcarbamoyl-5-iodo[2.2]paracyclophane in CDCl3.
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Figure S25. 13C NMR spectrum of 4-diethylcarbamoyl-5-iodo[2.2]paracyclophane in CDCl3.
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Figure S26. 1H NMR spectrum of 4-hydroxy-5-iodo[2.2]paracyclophane in CDCl3.
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Figure S27. 13C NMR spectrum of 4-hydroxy-5-iodo[2.2]paracyclophane in CDCl3.
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Figure S28. 1H NMR spectrum of 4-methoxy-5-iodo[2.2]paracyclophane in CDCl3.
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Figure S29. 13C NMR spectrum of 4-methoxy-5-iodo[2.2]paracyclophane in CDCl3
S41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S30. 1H NMR spectrum of 3(PF6) in CD3CN.
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Figure S31. 13C NMR spectrum of 3(PF6) in CD3CN.
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Figure S32. 1H-1H COSY NMR spectrum of 3(PF6) in CD3CN. 
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Figure S33. 19F NMR spectrum (benzene-d6) after thermal decomposition of 5(F) at 140 °C.  
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Figure S34. 19F NMR spectrum (benzene-d6) after thermal decomposition of 5(F) at 80 °C.  
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Figure S35. 1H NMR spectrum of 1(F) in C6D6. 
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Figure S36. 1H NMR spectrum of 2(F) in C6D6. 
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Figure S37. 19F NMR spectrum of 2(F) and 4‐fluorotoluene (standard) in C6D6. 
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Figure S38. 1H NMR spectrum of 3(F) in C6D6. 
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